The numerous CF animal models that develop airway disease similar to humans [162–165], as well as the multiple small molecules available that inhibit or potentiate NPY signaling [182, 189] offer ample opportunities to investigate the potential role of NPY in CF. Here, NPY is linked to cystic fibrosis.